Prediction of type 1 diabetes with machine learning algorithms based on FTIR spectral data in peripheral blood mononuclear cells.
Evita RostokaKarlis ShvirkstsEdgars SalnaIlva TrapinaAleksejs FedulovsMara GrubeJelizaveta SokolovskaPublished in: Analytical methods : advancing methods and applications (2023)
The incidence of autoimmunity is increasing, to ensure timely and comprehensive treatment, there must be a diagnostic method or markers that would be available to the general public. Fourier-transform infrared spectroscopy (FTIR) is a relatively inexpensive and accurate method for determining metabolic fingerprint. The metabolism, molecular composition and function of blood cells vary according to individual physiological and pathological conditions. Thus, by obtaining autoimmune disease-specific metabolic fingerprint markers in peripheral blood mononuclear cells (PBMC) and subsequently using machine learning algorithms, it might be possible to create a tool that will allow the diagnosis of autoimmune diseases. In this preliminary study, it was found that the peak shift at 1545 cm -1 could be considered specific for autoimmune disease type 1 diabetes (T1D), while the shifts at 1070 and 1417 cm -1 could be more attributed to the autoimmune condition per se . The prediction of T1D, despite the small number of participants in the study, showed an inverse AUC = 0.33 ± 0.096, n = 15, indicating a stable trend in the prediction of T1D based on FTIR metabolic fingerprint data in the PBMC.
Keyphrases
- machine learning
- type diabetes
- multiple sclerosis
- big data
- healthcare
- deep learning
- cardiovascular disease
- electronic health record
- artificial intelligence
- mental health
- glycemic control
- magnetic resonance
- oxidative stress
- drug induced
- quality control
- single molecule
- skeletal muscle
- combination therapy
- mass spectrometry
- smoking cessation
- replacement therapy